Micromet Financial Statements
Micromet Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Micromet Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 27.3 | 18.4 | 27.6 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (33.2) | (20.1) | (34.0) |
| Diluted EPS (Net Income) | (0.77) | (0.55) | (1.29) |
Micromet Quarterly Statements
| Quarter Ending Jun 09 | Quarter Ending Mar 09 | Quarter Ending Dec 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 4.9 | 7.5 | 5.9 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (13.9) | (0.3) | (5.9) |
| Diluted EPS (Net Income) | (0.27) | (0.01) | (0.10) |
Micromet Stock Quote & Chart
11/06/09 16:00:01 EST •
NASDAQ •
6.00
•
 +0.5100
•
+9.2896 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Micromet Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 10.53 | 7.55 | 7.01 |
| Price/Earnings Ratio | (8.06) | 93.46 | 25.51 |
| Price/Book Ratio | 12.61 | 3.48 | 6.74 |
| Price/Cash Flow Ratio | (17.61) | 41.49 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Micromet Financial Ratios
Micromet Competitive Intelligence
| Biogen Idec | Genentech | GlaxoSmithKline | |
|---|---|---|---|
| Annual Sales ($ mil.) | 4,097.5 | 13,418.0 | 35,244.6 |
| Employees | 4,700 | 11,174 | 99,003 |
| Market Cap ($ mil.) | 12,837.5 | -- | 114,528.4 |
Competitive Landscape
